Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Bestatin . hydrochloride
60
CHF
CHF 60.00
In stock
AG-CP3-7005-M0055 mgCHF 60.00
AG-CP3-7005-M02525 mgCHF 240.00
| Product Details | |
|---|---|
| Synonyms | Ubenimex; NK421; NSC265489; N-(3R-Amino-2S-hydroxy-1-oxo-4-phenylbutyl)-L-leucine |
| Product Type | Chemical |
| Properties | |
| Formula |
C16H24N2O4 . HCl |
| MW | 308.4 . 36.5 |
| CAS | 65391-42-6 |
| RTECS | OH2915000 |
| Source/Host Chemicals | Synthetic. Originally isolated from S. olivoreticuli. |
| Purity Chemicals | ≥98% (HPLC) |
| Appearance | White solid. |
| Solubility | Soluble in DMSO (10mg/ml), water (10mg/ml) or methanol (5mg/ml). |
| InChi Key | XGDFITZJGKUSDK-UDYGKFQRSA-N |
| Smiles | [NH3+][C@@H]([C@H](O)C(N[C@@H](CC(C)C)C(O)=O)=O)CC1=CC=CC=C1.[Cl-] |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light and moisture. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Antibiotic, protease inhibitor. Potent, competitive and specific aminopeptidase inhibitor. Can be administered in vitro to cultured cells or in vivo with low toxicity.
- Inhibits aminopeptidase B, aminopeptidase N, leucine aminopeptidase and the aminopeptidase activity of leukotriene A4 (LTA4) hydrolase. It is selective for these aminopeptidases over aminopeptidase A, trypsin, chymotrypsin, elastase, papain, pepsin and thermolysin.
- Immunomodulator. Displays immunostimulant activity via activation of macrophages and T lymphocytes. Displays anticancer and anti-inflammatory activity. Shown to inhibit proliferation, migration and invasion, and induces autophagy and apoptosis in cancer cells. Inhibits the production of LTB4 in erythrocytes.
- Has been used as useful tool to assess the physiological role of certain mammalian exopeptidases in the regulation of the immune system, the growth of tumors and their invasion of surrounding tissues and the degradation of cellular proteins.
Product References
- Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes: H. Umezawa, et al.; J. Antibiot. 29, 97 (1976)
- Low-molecular-weight enzyme inhibitors of microbial origin: H. Umezawa; Ann. Rev. Microbiol. 36, 75 (1982)
- Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells: W.E. Muller, et al.; Int. J. Immunopharmacol. 4, 393 (1982)
- Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes: D.H. Rich, et al.; J. Med. Chem. 27, 417 (1984)
- The slow, tight binding of bestatin and amastatin to aminopeptidases: S.H. Wilkes & J.M. Prescott; J. Biol. Chem. 260, 13154 (1985)
- Leukotriene A4 hydrolase. Inhibition by bestatin and intrinsic aminopeptidase activity establish its functional resemblance to metallohydrolase enzymes: L. Orning, et al.; J. Biol. Chem. 266, 1375 (1991)
- Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function: G. Mathe; Biomed. Pharmacother. 45, 49 (1991) (Review)
- Review of ubenimex (Bestatin): clinical research: K. Ota; Biomed. Pharmacother. 45, 55 (1991) (Review)
- Inhibitory effect of bestatin on the growth of human lymphocytes: K. Ino, et al.; Immunopharmacol. 23, 163 (1992)
- Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme: S. Tieku & N.M. Hooper; Biochem. Pharmacol. 44, 1725 (1992)
- Clinical trials of bestatin for leukemia and solid tumors: K. Ota & Y. Uzuka; Biotherapy 4, 205 (1992) (Review)
- Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines: K. Sekine, et al.; Leukemia 13, 729 (1999)
- Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice: Y. Aozuka, et al.; Cancer Lett. 216, 35 (2004)
- Bestatin, an inhibitor for aminopeptidases, modulates the production of cytokines and chemokines by activated monocytes and macrophages: B. Lkhagvaa, et al.; Cytokine 44, 386 (2008)
- The Analgesic Activity of Bestatin as a Potent APN Inhibitor: M.R. Jia, et al.; Front. Neurosci. 4, 50 (2010) (Review)
- Ubenimex, an APN inhibitor, could serve as an anti‑tumor drug in RT112 and 5637 cells by operating in an Akt‑associated manner: X. Wang, et al.; Mol. Med. Rep. 17, 4531 (2018)
- Inhibition of LTA4H by bestatin in human and mouse colorectal cancer: S. Zhao, et al.; EBioMedicine 44, 361 (2019)
Related Products
